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Abstract: 
Macrocyclic trichothecenes, which have potent cytotoxicity, have been isolated from many 
different fungal species. These compounds were evaluated clinically by the U.S. National Cancer 
Institute in the 1970's and 1980's. However, they have yet to be advanced into viable drugs due 
to severe side effects. Our team is investigating a diverse library of filamentous fungi for new 
anticancer leads. To avoid re-isolating macrocyclic trichothecenes via bioactivity-directed 
fractionation studies, a protocol for their facile dereplication was developed. The method uses 
readily available photodiode array detectors to identify one of two types of characteristic UV 
spectra for these compounds. Also, diagnostic signals can be observed in the 1H-NMR spectra, 
particularly for the epoxide and conjugated diene moieties, even at the level of a crude extract. 
Using these techniques in a complementary fashion, macrocyclic trichothecenes can be 
dereplicated rapidly. 
 
Article: 
INTRODUCTION 
Macrocyclic trichothecenes (MTs) are a class of sesquiterpene lactones that are reported to have 
a wide array of biological activities, including: antimalarial,1,2,3 antileukemic,4 antibiotic,5 
antifungal,6 antiviral,7 and anticancer.8,9,10,11 According to Grove,12 they were first described in 
1946 and isolated in pure form in 1962, and their potent biological activity and interesting 
chemistry stimulated a large amount of research throughout the 1970s and 1980s. Grove's 
comprehensive review12 of the literature on MTs through 1991 should be referenced for more 
complete details on the history, chemistry, and structural variants of MTs, which at that time 
were noted at over 60 distinct compounds and today probably represent over 100 compounds.1,13 
Moreover, Jarvis and Mazzola4 reviewed both the biological activity of these compounds, which 
are reported to effect cell growth via inhibition of protein synthesis, and their evaluation against 
in vivo models of cancer by the U.S. National Cancer Institute (NCI). Jarvis and colleagues 
conducted medicinal chemistry studies on analogs of the MTs as well.14,15 Yet, despite 
evaluating over 90 natural and synthetic analogs of MTs in in vitro and in vivo models of cancer, 
only two MTs were evaluated clinically by the NCI, and both were dropped due to severe 
toxicity (D.J. Newman, National Cancer Institute, Frederick, MD, USA, personal 
communication). 
 
In the course of our early research on filamentous fungi, a project that targets the isolation of 
structurally unique compounds with potent anticancer activity,16,17 several macrocyclic 
trichothecenes [e.g. verrucarin A (1) and roridin E (2)] were isolated via bioactivity-directed 
fractionation based on cytotoxic activity vs a human tumor panel consisting of three cell lines. 
Not surprisingly based on the literature, these MTs and related analogs were quite cytotoxic, 
being on the same order of potency as the positive control, camptothecin, even when the MTs 
were present at a low concentration in a crude extract. As such, the exciting cytotoxicity results 
skewed the chemistry efforts towards the isolation and elucidation of known MTs and/or closely 
related analogs, and in turn, pulled resources away from the discovery of bioactive leads with 
new structural types. 
 
What was needed to circumvent this problem was a procedure to dereplicate MTs, particularly at 
the level of the crude extract and using techniques and tools that were readily available at the 
bench. Since most of the filamentous fungi under examination for this project, sampled from a 
library of over 50,000 isolates, were of unknown taxonomy at the time of initial evaluation,16 
genera well known to produce MTs (e.g., Fusarium spp., Myrothecium spp., Stachybotrys spp., 
and Trichothecium spp.)4 could not be eliminated indiscriminately; other authors have noted 
similar challenges when relying upon the taxonomy of fungi for dereplication.18 Moreover, with 
three notable exceptions,13,18,19 the literature on analytical dereplication procedures for MTs was 
scant, probably because, as Grove observed,12 MTs have not been implicated as key mycotoxin 
contaminants of grain or grain products, and thus, there has not been a demand to develop 
analytical methods for their rapid identification/quantification. The exceptions were promising 
and comprehensive, however, two relied upon techniques and tools that may not be available in 
all laboratories, namely HRMS18 and capillary flow NMR.19 The third was more accessible, 
using photodiode array detection, although it focused on toxins of Stachybotrys sp.;13 methods 
that could be applied to all structural variants of MTs were needed. 
 
Thus, a dereplication strategy was developed and implemented that capitalized upon the UV (via 
photodiode array detection) and 1H NMR spectra. The procedure discerns readily samples that 
contain MTs, and the pattern recognition afforded by the UV spectra makes the strategy 
straightforward to implement. 
 
RESULTS AND DISCUSSION 
Key structural features of macrocyclic trichothecenes 
Macrocyclic trichothecenes (MTs) are comprised of several structural features that are 
discernable in the 1H NMR and/or UV spectra (Table 1). When coupled together, and supported 
by potent cytotoxicity, these features permitted the facile dereplication of even crude extracts for 
MTs. The most telling feature in the 1H NMR spectrum may be the epoxide ring across positions 
C-12 to C-13, which is present in all but three MTs,12 and the cytotoxicity of this class of 
compounds was reported to decrease substantially when this moiety was absent.20 The two 
protons of the epoxide, H-13a and H-13b, displayed characteristic doublets (J=4 Hz) in the 1H 
NMR spectrum at approximately δ 3.10 and 2.78. The sesquiterpene core of the molecule has a 
mono-substituted double bond across positions C-9 to C-10, and this rendered two more 
distinguishing features in the 1H NMR spectrum. The only proton of this double bond, H-10, 
displayed a broad doublet at approximately δ 5.45 (J=6 Hz). Moreover, the methyl substituent at 
position C-9 (i.e. methyl C-16) displayed a singlet for H3-16 at approximately δ 1.73; at higher 
field, allylic coupling of ~1 Hz may be observed between H3-16 and H-10. Finally, the 
macrocycle moiety, which loops from C-4 to C-15 via a carbon chain of variable lengths 
(typically C11 or C12 chains), includes α,β-unsaturated lactone moieties that provided key 
spectroscopic features, particularly in UV spectra.18 In the case of compounds like verrucarin A 
(1), there was a single UV maximum at approximately 260 nm. Whereas, in the case of 
compounds like roridin E, the additional unsaturated carbonyl accounts for a second UV peak at 
approximately 230 nm. These dienes also produced key signals in the olefinic region of the 1H 
NMR (i.e. δ 5.72 – 8.01), but the UV spectrum provides a tool that is readily discernable. In 
summary, when an active extract was identified, if these key structural features were noted in 
the 1H NMR data and/or the UV spectrum (Table 1), then the activity of the fungus was ascribed 
with great confidence to MTs. 
 
Table 1: Key structural features and spectroscopic properties of macrocyclic trichothecenes. 
Structural Feature Spectroscopic Properties 
Epoxide across positions C-12 to C-13 Two prominent doublets (H-13a and H-13b) in the 1H NMR spectrum 
(e.g. δ 3.10 and 2.78; J = 4 Hz). 
 
Double bond across positions C-9 to C-10 Prominent broad doublet (with possible allylic coupling at higher field) 
in 1H NMR spectrum for H-10 (e.g. δ 5.45). 
 
Vinyl methyl group at position C-16 Prominent singlet (with possible allylic coupling at higher field) in 1H 
NMR spectrum (e.g. δ 1.73). 
 
Two α,β-unsaturated lactone moieties at positions C-6' to C-11' [e.g. 
compounds similar to verrucarin A (1)]. 
 
Prominent UV spectrum with a single maximum (λ ~ 260 nm). 
Additional α,β-unsaturated lactone moieties at positions C-1' to C-3' 
[e.g. compounds similar to roridin E (2)]. 
Prominent UV spectrum with two maxima (λ ~ 260 and 230 nm). 
 
Development of the dereplication methodology 
Initial screening of 154 organic extracts of filamentous fungi for cytotoxicity against a human 
tumor panel resulted in the identification of eight active samples, two of which were the most 
potent. One of these two was carried through a bioactivity-directed fractionation. After several 
rounds of chromatography followed by assessment of cytotoxicity, the activity could be ascribed 
to two known compounds, the macrocyclic trichothecenes verrucarin A (1) and roridin E (2), 
among other similar compounds; the 1H and 13C NMR data for 1 and 2 were in excellent 
agreement with the literature.1,6,21,22 The taxonomy of the fungus (MSX 28737) was evaluated 
and found to be closely related to Myrothecium roridum, a known producer of MTs.23 However, 
at the time of initial examination, the taxonomy of the fungus was unknown. 
 
The isolation of these two known MTs was somewhat disappointing, and the team feared that the 
potent activity of other extracts could be due to similar MTs. Thus, the MTs isolated from MSX 
28737 were used as reference standards to develop the dereplication methodology. Figures 1 and 
and22 display the structures of compounds 1 and 2 and their corresponding UV and 1H NMR 
spectra. Prominent signals in the NMR spectra (Fig. 2) are notated as they relate to the key 
signals outlined in Table 1. Specifically, the epoxide protons (H2-13), the olefinic proton (H-10), 
and the vinylic methyl group (H3-16) were observed in both compounds 1 and 2. If there were 
major differences between the two with respect to their 1H NMR spectra, it was only the larger 
number of olefinic signals observed in compound 2. However, the key differences between the 
verrucarin-like compounds (based on 1) and the roridin-like compounds (based on 2) was 
discernable in the UV spectra (Fig. 1). The macrocyclic portion of 1 resulted in a single UV 
maximum (~260 nm), whereas the added unsaturation in the macrocycle of 2 resulted in two UV 
maxima (~260 and 230 nm). In essence, these two pieces of spectroscopic data (1H NMR and 
UV), both of which can be acquired readily on relatively crude extracts, work in a 
complementary fashion to dereplicate MTs. The 1H NMR data identified key features of the 
sesquiterpene core (e.g., epoxide, monosubstituted olefin, vinylic methyl group), while the UV 
data identified aspects of the macrocycle (e.g., more or less unsaturation). In particular, the 
visual nature of the UV spectrum may be the most straightforward to recognize. For example, 
Figure 3 displays a prep-HPLC chromatogram of an active fraction, and several peaks have a UV 
profile based on the roridin-like compounds, further justifying the dereplication of this sample. 
 
Figure 1: Structures and UV profiles of verrucarin A (1) and roridin E (2). 
 
 
 
 
Figure 2: 1H NMR spectra of the MTs, roridin E (2) and verrucarin A (1), and a crude extract 
that was dereplicated for MTs. The oval highlights the typical region for the chemical shifts of 
epoxide protons. The rectangle highlights the typical region for the chemical (more ...) 
 
 
Use of the dereplication methodology 
Over the past year, this dereplication methodology has been used routinely on scores of cytotoxic 
extracts of filamentous fungi. For this, the goal was either 1) to determine that the cytotoxicity 
could be ascribed to macrocyclic trichothecenes (MTs), in which case samples were dropped, or 
2) to determine that the cytotoxicity cannot be ascribed to MTs, in which case samples were 
prioritized for bioactivity-directed fractionation. 
 
The case of fungal strain MSX 15962 illustrates the use of these spectral techniques for 
dereplication (Table 1), especially when the taxonomy of the fungus did not suggest MTs. For 
example, based on the taxonomy of MSX 15962, which was found to be closely related to 
Gliocladium viride, one would not expect MTs. However, the 1H NMR data (Figure 2) displayed 
some of the key signals of MTs. The methylene epoxide protons (encircled in Figure 2) were in 
the expected region, even when partially obscured at the level of the crude extract. Moreover, the 
downfield region (from ~6 to 8 ppm; Figure 2) had signals typical of the MT olefinic protons. 
After initial rounds of bioactivity-directed fractionation, the activity concentrated in an HPLC 
fraction where the UV spectrum was diagnostic for roridin-type compounds (Figure 4). In short, 
the spectroscopic signatures of MTs, noted in both 1H NMR and UV spectra of active fractions, 
permitted dereplication of this sample. 
 
Figure 3: Prep-HPLC chromatogram (top) and UV spectra (bottom) of several potential MTs 
with a roridin-type macrocycle from another fraction of Myrothecium roridum (MSX 28737). 
 
 
 
 
 
 
Figure 4: HPLC chromatogram (left) and UV spectrum (right) of an active fraction of MSX 
15962. 
 
 
 
Conclusion 
A method to dereplicate extracts of filamentous fungi for macrocyclic trichothecenes (MTs) was 
developed and implemented. The method utilized tools and instrumentation common to most 
laboratories of natural products, particularly the 1H NMR and UV spectra. The pattern 
recognition afforded by these spectral techniques does not require sophisticated training of 
laboratory staff, and the methods were quite versatile, being applicable to crude extracts, 
partially purified mixtures, and pure compounds. 
 
EXPERIMENTAL SECTION 
General 
All 1H NMR experiments were performed in CDCl3 with TMS as an internal standard and were 
acquired on either a Varian Unity INOVA-500 or a JEOL ECA-500. Flash chromatography was 
conducted using a CombiFlash Rf system using RediSep Rf Si-gel columns (both from 
Teledyne-Isco; Lincoln, NE, USA). HPLC was carried out on Varian Prostar HPLC systems 
(Walnut Creek, CA, USA) equipped with Prostar 210 pumps and a Prostar 335 photodiode array 
detector (PDA), with data collected and analyzed using Galaxie Chromatography Workstation 
software (version 1.9.3.2). For preparative HPLC, YMC ODS-A (5 μm; 250 × 20 mm) columns 
were used with a 10 mL/min flow rate, while for analytical HPLC, YMC ODS-A (5 μm; 150 × 
4.6 mm) columns were used with a 1 mL/min flow rate (both from Waters; Milford, MA, USA). 
For analytical HPLC, MetaTherm HPLC column temperature controllers (Varian) maintained 
these columns at 30°C. 
 
Producing Organisms 
Both producing fungi were from the Mycosynthetix culture collection. MSX 28737 was isolated 
from a sample of leaf litter, and the closest match using DNA analysis suggested it was 
Myrothecium roridum. MSX 15962 was isolated from aerial leaves in a varzea community from 
an area which was occasionally flooded, and the closest match using DNA analysis suggested it 
was Gliocladium viride. DNA analyses were performed by MIDI Labs Inc (Newark, DE, USA), 
and the D2 variable region of the Large Subunit (LSU) rRNA was sequenced and compared to 
the MIDI Labs database. 
 
Fermentations 
The cultures were grown on solid medium prepared using 12 g of rice to which was added 24 mL 
of YESD medium prepared by adding yeast extract (2% w/v), soy peptone (2%), dextrose (2%), 
and malt extract (1%) in water in 250 mL Erlenmeyer flasks. This was sterilized at 121°C for 20 
min. For large scale cultures, similar conditions were used, scaling to 150 g of rice and 300 mL 
of YESD medium in 2.8 L Fernback flasks. Cultures were inoculated either directly from a slant 
(small flasks), or for larger fermentations, by using an inoculum prepared by growing the fungus 
in a 50 mL polypropylene centrifuge tube containing 7 mL of YESD medium incubated for 7 d 
at 22°C with agitation. The cultures were incubated at 22°C for 7 to 14 d at which time they were 
extracted. 
 
Extraction and Isolation 
A solid phase fungal culture of MSX 28737 was scored with a spatula and submerged with 60 
mL of 1:1 CHCl3:MeOH and shaken overnight at 135 rpm in a Lab-line Environ-shaker (Thermo 
Scientific, Waltham, MA). The resultant solution was filtered on a Buchner funnel using 
Whatman #1 filter paper, and 90 mL of CHCl3 and 150 mL of H2O were added to the filtrate to 
generate a biphasic solution of 4:1:5 (CHCl3:MeOH:H2O). This solution was stirred for 2 hrs, 
transferred to a separatory funnel, and the organic layer (lower) was removed. This organic 
extract was dried in vacuo (127 mg) and then defatted via partitioning between hexane and 
CH3CN. The CH3CN sample was dried (41 mg) and subjected to reversed-phase HPLC (60:40 
to 100:0 CH3CN:H2O over 120 min) to afford nine fractions. Fractions 3 and 5, both active in 
the cytotoxicity assay, were identified as verrucarin A (1, 1 mg) and roridin E (2, 1 mg); both 
compounds were >96% pure by analytical RP-HPLC. 
 
A generalized methodology for dereplication of MTs begins by using essentially the same 
procedures outlined above, resulting in a defatted CH3CN-soluble sample. This organic extract is 
then subjected to flash column chromatography using a RediSep Si-gel column and a two stage 
gradient (100:0 to 0:100 Hexane:CHCl3 then 100:0 to 75:25 CHCl3:MeOH) over 70 column 
volumes total. Active pools from the initial column are then profiled by obtaining a 1H NMR 
spectrum and performing analytical reversed-phase HPLC on a system equipped with a PDA 
detector. 
 
Cytotoxicity Assays 
The cytotoxicity measurements were carried out as described previously24 and with the recently 
noted modification.25 
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